Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia/reperfusion injury

European Journal of Pharmacology

Volumn 799, Issue , 2017, Pages 128-134

  Fouda, Abdelrahman Y ^a   Pillai, Bindu ^a   Dhandapani, Krishnan M ^b   Ergul, Adviye ^a,b   Fagan, Susan C ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

And Interleukin 10; Angiotensin Type 2 Receptor; Compound 21; Neuroprotection; Stroke

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; INTERLEUKIN 10; TUMOR NECROSIS FACTOR; ANGIOTENSIN 2 RECEPTOR; N-BUTYLOXYCARBONYL-3-(4-IMIDAZOL-1-YLMETHYLPHENYL)-5-ISOBUTYLTHIOPHENE-2-SULFONAMIDE; NEUROPROTECTIVE AGENT; OXYGEN; SULFONAMIDE; THIOPHENE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; EMBRYO; IN VITRO STUDY; IN VIVO STUDY; LIMIT OF QUANTITATION; MALE; NEUROPROTECTION; NONHUMAN; OXYGEN GLUCOSE DEPRIVATION; PROTEIN FUNCTION; RAT; REOXYGENATION; REPERFUSION INJURY; WESTERN BLOTTING; AGONISTS; ANIMAL; CEREBRAL ARTERY DISEASE; COMPLICATION; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERLEUKIN-10; MALE; NEUROPROTECTIVE AGENTS; OXYGEN; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 2; REPERFUSION INJURY; SULFONAMIDES; THIOPHENES;

EID: 85012940606     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2017.02.016     Document Type: Article

References (39)

1. Alhusban, A., Fouda, A.Y., Bindu, P., Ishrat, T., Soliman, S., Fagan, S.C., Compound 21 is pro-angiogenic in the brain and results in sustained recovery after ischemic stroke. J. Hypertens. 33 (2015), 170–180.
2. Bachis, A., Colangelo, A.M., Vicini, S., Doe, P.P., De Bernardi, M.A., Brooker, G., Mocchetti, I., Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J. Neurosci. 21 (2001), 3104–3112.
3. Bederson, J.B., Pitts, L.H., Tsuji, M., Nishimura, M.C., Davis, R.L., Bartkowski, H., Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke; a J. Cereb. Circ. 17 (1986), 472–476.
4. Bitto, A., Polito, F., Irrera, N., Calo, M., Spaccapelo, L., Marini, H.R., Giuliani, D., Ottani, A., Rinaldi, M., Minutoli, L., Guarini, S., Squadrito, F., Altavilla, D., Protective effects of melanocortins on short-term changes in a rat model of traumatic brain injury*. Crit. care Med. 40 (2012), 945–951.
5. Bodhankar, S., Chen, Y., Vandenbark, A.A., Murphy, S.J., Offner, H., IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke. Metab. brain Dis. 28 (2013), 375–386.
6. Bodhankar, S., Chen, Y., Vandenbark, A.A., Murphy, S.J., Offner, H., Treatment of experimental stroke with IL-10-producing B-cells reduces infarct size and peripheral and CNS inflammation in wild-type B-cell-sufficient mice. Metab. brain Dis. 29 (2014), 59–73.
7. Cai, Z.P., Parajuli, N., Zheng, X., Becker, L., Remote ischemic preconditioning confers late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10. Basic Res. Cardiol., 107, 2012, 277.
8. Curato, C., Slavic, S., Dong, J., Skorska, A., Altarche-Xifro, W., Miteva, K., Kaschina, E., Thiel, A., Imboden, H., Wang, J., Steckelings, U., Steinhoff, G., Unger, T., Li, J., Identification of noncytotoxic and IL-10-producing CD8+AT2R+ T cell population in response to ischemic heart injury. J. Immunol. (Baltim., Md.: 1950) 185 (2010), 6286–6293.
9. Dhandapani, K., Brann, D., Neuroprotective effects of estrogen and tamoxifen in vitro: a facilitative role for glia?. Endocrine 21 (2003), 59–66.
10. Dhande, I., Ali, Q., Hussain, T., Proximal tubule angiotensin AT2 receptors mediate an anti-inflammatory response via interleukin-10: role in renoprotection in obese rats. Hypertension 61 (2013), 1218–1226.
11. Dhande, I., Ma, W., Hussain, T., Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin-10 production. Hypertens. Res.: Off. J. Jpn. Soc. Hypertens. 38 (2015), 21–29.
12. Fagan, S.C., Kozak, A., Hill, W.D., Pollock, D.M., Xu, L., Johnson, M.H., Ergul, A., Hess, D.C., Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection. J. Hypertens. 24 (2006), 535–539.
13. Fouda, A., Kozak, A., Alhusban, A., Switzer, J., Fagan, S., Anti-inflammatory IL-10 is upregulated in both hemispheres after experimental ischemic stroke: hypertension blunts the response. Exp. Transl. Stroke Med., 5, 2013, 12.
14. Fouda, A.Y., Alhusban, A., Ishrat, T., Pillai, B., Eldahshan, W., Waller, J.L., Ergul, A., Fagan, S.C., Brain-derived neurotrophic factor knockdown blocks the angiogenic and protective effects of angiotensin modulation after experimental stroke. Mol. Neurobiol., 2016.
15. Grilli, M., Barbieri, I., Basudev, H., Brusa, R., Casati, C., Lozza, G., Ongini, E., Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur. J. Neurosci. 12 (2000), 2265–2272.
16. Guan, W., Somanath, P.R., Kozak, A., Goc, A., El-Remessy, A.B., Ergul, A., Johnson, M.H., Alhusban, A., Soliman, S., Fagan, S.C., Vascular protection by angiotensin receptor antagonism involves differential VEGF expression in both hemispheres after experimental stroke. PLoS One, 6, 2011, e24551.
17. Ishrat, T., Mohamed, I.N., Pillai, B., Soliman, S., Fouda, A.Y., Ergul, A., El-Remessy, A.B., Fagan, S.C., Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice. Mol. Neurobiol. 51 (2015), 766–778.
18. Joseph, J.P., Mecca, A.P., Regenhardt, R.W., Bennion, D.M., Rodriguez, V., Desland, F., Patel, N.A., Pioquinto, D.J., Unger, T., Katovich, M.J., Steckelings, U.M., Sumners, C., The angiotensin type 2 receptor agonist compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke. Neuropharmacology 81c (2014), 134–141.
19. Kozak, W., Kozak, A., Johnson, M.H., Elewa, H.F., Fagan, S.C., Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response study. J. Pharmacol. Exp. Ther. 326 (2008), 773–782.
20. Lee, S., Brait, V.H., Arumugam, T.V., Evans, M.A., Kim, H.A., Widdop, R.E., Drummond, G.R., Sobey, C.G., Jones, E.S., Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivo. Exp. Transl. Stroke Med., 4, 2012, 16.
21. Liesz, A., Suri-Payer, E., Veltkamp, C., Doerr, H., Sommer, C., Rivest, S., Giese, T., Veltkamp, R., Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 15 (2009), 192–199.
22. Liesz, A., Zhou, W., Na, S.Y., Hammerling, G.J., Garbi, N., Karcher, S., Mracsko, E., Backs, J., Rivest, S., Veltkamp, R., Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. J. Neurosci.: Off. J. Soc. Neurosci. 33 (2013), 17350–17362.
23. McCarthy, C.A., Vinh, A., Miller, A.A., Hallberg, A., Alterman, M., Callaway, J.K., Widdop, R.E., Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats. PloS One, 9, 2014, e95762.
24. McCarthy, C.A., Widdop, R.E., Deliyanti, D., Wilkinson-Berka, J.L., Brain and retinal microglia in health and disease: an unrecognized target of the renin-angiotensin system. Clin. Exp. Pharmacol. Physiol. 40 (2013), 571–579.
25. Min, L.J., Mogi, M., Tsukuda, K., Jing, F., Ohshima, K., Nakaoka, H., Kan-No, H., Wang, X.L., Chisaka, T., Bai, H.Y., Iwanami, J., Horiuchi, M., Direct stimulation of angiotensin II Type 2 receptor initiated after stroke ameliorates ischemic brain damage. Am. J. Hypertens., 2014.
26. Murray, P.J., The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc. Natl. Acad. Sci. USA 102 (2005), 8686–8691.
27. Namsolleck, P., Boato, F., Schwengel, K., Paulis, L., Matho, K.S., Geurts, N., Thone-Reineke, C., Lucht, K., Seidel, K., Hallberg, A., Dahlof, B., Unger, T., Hendrix, S., Steckelings, U.M., AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression. Neurobiol. Dis. 51 (2013), 177–191.
28. Ooboshi, H., Ibayashi, S., Shichita, T., Kumai, Y., Takada, J., Ago, T., Arakawa, S., Sugimori, H., Kamouchi, M., Kitazono, T., Iida, M., Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation 111 (2005), 913–919.
29. Sabat, R., Grutz, G., Warszawska, K., Kirsch, S., Witte, E., Wolk, K., Geginat, J., Biology of interleukin-10. Cytokine Growth Factor Rev. 21 (2010), 331–344.
30. Schwengel, K., Namsolleck, P., Lucht, K., Clausen, B.H., Lambertsen, K.L., Valero-Esquitino, V., Thone-Reineke, C., Muller, S., Widdop, R.E., Denton, K.M., Horiuchi, M., Iwai, M., Boato, F., Dahlof, B., Hallberg, A., Unger, T., Steckelings, U.M., Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice. J. Mol. Med. (Berl., Ger.) 94 (2016), 957–966.
31. Sharma, S., Yang, B., Xi, X., Grotta, J.C., Aronowski, J., Savitz, S.I., IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways. Brain Res. 1373 (2011), 189–194.
32. Shraim, N., Mertens, B., Clinckers, R., Sarre, S., Michotte, Y., Van Eeckhaut, A., Microbore liquid chromatography with UV detection to study the in vivo passage of compound 21, a non-peptidergic AT(2) receptor agonist, to the striatum in rats. J. Neurosci. Methods 202 (2011), 137–142.
33. Skorska, A., von Haehling, S., Ludwig, M., Lux, C.A., Gaebel, R., Kleiner, G., Klopsch, C., Dong, J., Curato, C., Altarche-Xifro, W., Slavic, S., Unger, T., Steinhoff, G., Li, J., David, R., The CD4(+) AT2R(+) T cell subpopulation improves post-infarction remodelling and restores cardiac function. J. Cell. Mol. Med. 19 (2015), 1975–1985.
34. Spaccapelo, L., Galantucci, M., Neri, L., Contri, M., Pizzala, R., D'Amico, R., Ottani, A., Sandrini, M., Zaffe, D., Giuliani, D., Guarini, S., Up-regulation of the canonical Wnt-3A and Sonic hedgehog signaling underlies melanocortin-induced neurogenesis after cerebral ischemia. Eur. J. Pharmacol. 707 (2013), 78–86.
35. Spera, P.A., Ellison, J.A., Feuerstein, G.Z., Barone, F.C., IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett. 251 (1998), 189–192.
36. Valenzuela, R., Costa-Besada, M.A., Iglesias-Gonzalez, J., Perez-Costas, E., Villar-Cheda, B., Garrido-Gil, P., Melendez-Ferro, M., Soto-Otero, R., Lanciego, J.L., Henrion, D., Franco, R., Labandeira-Garcia, J.L., Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration. Cell death Dis., 7, 2016, e2427.
37. Wang, J., Pang, T., Hafko, R., Benicky, J., Sanchez-Lemus, E., Saavedra, J.M., Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARgamma activation. Neuropharmacology 79 (2014), 249–261.
38. Watanabe, T., Okuda, Y., Nonoguchi, N., Zhao, M.Z., Kajimoto, Y., Furutama, D., Yukawa, H., Shibata, M.A., Otsuki, Y., Kuroiwa, T., Miyatake, S., Postischemic intraventricular administration of FGF-2 expressing adenoviral vectors improves neurologic outcome and reduces infarct volume after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow. Metab.: Off. J. Int. Soc. Cereb. Blood Flow. Metab. 24 (2004), 1205–1213.
39. Wu, X., Kihara, T., Hongo, H., Akaike, A., Niidome, T., Sugimoto, H., Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletion. Br. J. Pharmacol. 161 (2010), 33–50.